NCT00295919 2026-04-14N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent NeuroblastomaNew Approaches to Neuroblastoma Therapy ConsortiumPhase 1 Completed80 enrolled